PWM
Prentice Wealth Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
6,129
-110
| -2% | -$20.4K | 0.3% | 42 |
|
|
2025
Q1 | $1.31M | Sell |
6,239
-28
| -0.4% | -$5.87K | 0.38% | 38 |
|
|
2024
Q4 | $1.11M | Buy |
6,267
+190
| +3% | +$33.8K | 0.32% | 40 |
|
|
2024
Q3 | $1.2M | Sell |
6,077
-15
| -0.2% | -$2.96K | 0.36% | 37 |
|
|
2024
Q2 | $1.04M | Buy |
6,092
+28
| +0.5% | +$4.8K | 0.34% | 41 |
|
|
2024
Q1 | $1.1M | Buy |
6,064
+212
| +4% | +$38.6K | 0.38% | 37 |
|
|
2023
Q4 | $907K | Buy |
5,852
+339
| +6% | +$52.5K | 0.35% | 35 |
|
|
2023
Q3 | $822K | Buy |
5,513
+30
| +0.5% | +$4.47K | 0.37% | 35 |
|
|
2023
Q2 | $739K | Buy |
5,483
+658
| +14% | +$88.7K | 0.34% | 36 |
|
|
2023
Q1 | $769K | Buy |
4,825
+36
| +0.8% | +$5.74K | 0.37% | 35 |
|
|
2022
Q4 | $774K | Buy |
4,789
+122
| +3% | +$19.7K | 0.39% | 29 |
|
|
2022
Q3 | $629K | Buy |
4,667
+267
| +6% | +$36K | 0.34% | 28 |
|
|
2022
Q2 | $674K | Buy |
4,400
+80
| +2% | +$12.3K | 0.69% | 19 |
|
|
2022
Q1 | $702K | Buy |
4,320
+125
| +3% | +$20.3K | 0.34% | 30 |
|
|
2021
Q4 | $572K | Sell |
4,195
-88
| -2% | -$12K | 0.27% | 39 |
|
|
2021
Q3 | $462K | Buy |
4,283
+45
| +1% | +$4.85K | 0.22% | 49 |
|
|
2021
Q2 | $477K | Buy |
4,238
+798
| +23% | +$89.8K | 0.24% | 43 |
|
|
2021
Q1 | $372K | Buy |
+3,440
| New | +$372K | 0.21% | 49 |
|